PrimeX News

Broker News

US Dollar Forecast: DXY Gains as Fed Cut Odds Hold and Currencies Reverse
Sat, 18 Apr 2026 09:41:39 GMT
XRP News Today: Ripple Bulls Unsure of Trump’s Nuclear Peace Claims
Sat, 18 Apr 2026 08:31:49 GMT
AUD/USD Price Forecast: Aussie Paradox Peaks as Diplomacy Thaw Fuels 0.7200 Breakout
Sat, 18 Apr 2026 02:00:12 GMT
ASX 200 Forecast: Tech Strength Supports Recovery as Bank Yield Appeal Fades
Sat, 18 Apr 2026 00:00:10 GMT
S&P 500 Forecast: SPX Smashes 7,100 as Hormuz Reopening Triggers Peace Dividend Rally
Fri, 17 Apr 2026 22:02:12 GMT
TeraWulf (WULF) Price Forecast: Breakout Retest Signals Trend Continuation
Fri, 17 Apr 2026 21:11:50 GMT

Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Mon, 13 Apr 2026 16:16:44 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 26 Mar 2026 21:25:31 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Mon, 16 Mar 2026 13:30:15 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT
NVIDIA’s Record Quarter Reinforces Its Leadership in the Rapidly Growing AI Era
Wed, 25 Feb 2026 22:43:02 GMT
Amazon Plunges 9% After Hours as $200B Spending Plan Shocks Wall Street Investors
Thu, 05 Feb 2026 22:17:31 GMT

What Are Leveraged and Inverse ETFs? Risks, Rewards, and Key Strategies
Mon, 23 Mar 2026 23:55:30 GMT
Bollinger Bands Trading Strategies: How to Read Volatility, Identify Market Regimes, and Trade with a Statistical Edge
Fri, 13 Mar 2026 22:59:16 GMT
Moving Averages Explained: A Beginner’s Guide to SMA and EMA Trading Strategies
Wed, 11 Mar 2026 17:49:10 GMT
What Is Multi-Timeframe Analysis? How to Align Weekly, Daily, and Hourly Charts
Mon, 16 Mar 2026 14:14:48 GMT
Trend Identification & Analysis: How to Read the Market’s Footprints Before the Crowd Does
Fri, 27 Feb 2026 21:34:32 GMT
Support and Resistance: Finding Key Levels for Profitable Trading
Wed, 25 Feb 2026 22:45:24 GMT

Advertisement

Advertisement

APLS

Apellis Pharmaceuticals, Inc. Common Stock

40.90

USD

Sponsored

+0.03

+0.07%

Apr 17, 16:00 UTC -4

Closed

exchange

After-Market

40.92

+0.02

+0.06%

APLS News & Forecasts

featured

Zacks Investment Research

Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last?

featured

Why This Pharma Stock More Than Doubled Today

featured

Zacks Investment Research

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

featured

The Motley Fool

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story

featured

Apellis Pharmaceuticals, Inc. (APLS) Presents at TD Cowen 46th Annual Health Care Conference Transcript

featured

Zacks Investment Research

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

featured

Zacks Investment Research

Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates

featured

Zacks Investment Research

Apellis Pharmaceuticals (APLS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

featured

Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript

featured

Zacks Investment Research

Earnings Preview: Apellis Pharmaceuticals, Inc. (APLS) Q4 Earnings Expected to Decline

featured

Zacks Investment Research

Apellis Pharmaceuticals (APLS) Surges 5.8%: Is This an Indication of Further Gains?

featured

Apellis Valuation Ignores Empaveli Potential, Says Analyst

Advertisement

Advertisement

Advertisement